rs241419

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_002800.5(PSMB9):​c.94G>A​(p.Val32Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0244 in 1,612,750 control chromosomes in the GnomAD database, including 621 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.025 ( 82 hom., cov: 31)
Exomes 𝑓: 0.024 ( 539 hom. )

Consequence

PSMB9
NM_002800.5 missense

Scores

6
11

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 5.07

Publications

27 publications found
Variant links:
Genes affected
PSMB9 (HGNC:9546): (proteasome 20S subunit beta 9) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 1 (proteasome beta 6 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. [provided by RefSeq, Mar 2010]
PSMB9 Gene-Disease associations (from GenCC):
  • proteasome-associated autoinflammatory syndrome 3
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006846845).
BP6
Variant 6-32856171-G-A is Benign according to our data. Variant chr6-32856171-G-A is described in ClinVar as Benign. ClinVar VariationId is 3056957.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0247 (3765/152264) while in subpopulation AFR AF = 0.0373 (1550/41534). AF 95% confidence interval is 0.0358. There are 82 homozygotes in GnomAd4. There are 1684 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 82 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB9NM_002800.5 linkc.94G>A p.Val32Ile missense_variant Exon 2 of 6 ENST00000374859.3 NP_002791.1 P28065-1A0A1U9X8D7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB9ENST00000374859.3 linkc.94G>A p.Val32Ile missense_variant Exon 2 of 6 1 NM_002800.5 ENSP00000363993.2 P28065-1

Frequencies

GnomAD3 genomes
AF:
0.0247
AC:
3762
AN:
152146
Hom.:
82
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0374
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0310
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0233
Gnomad OTH
AF:
0.0349
GnomAD2 exomes
AF:
0.0163
AC:
4020
AN:
246636
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.0357
Gnomad AMR exome
AF:
0.0193
Gnomad ASJ exome
AF:
0.00662
Gnomad EAS exome
AF:
0.00284
Gnomad FIN exome
AF:
0.00328
Gnomad NFE exome
AF:
0.0219
Gnomad OTH exome
AF:
0.0203
GnomAD4 exome
AF:
0.0243
AC:
35510
AN:
1460486
Hom.:
539
Cov.:
30
AF XY:
0.0232
AC XY:
16867
AN XY:
726568
show subpopulations
African (AFR)
AF:
0.0358
AC:
1197
AN:
33470
American (AMR)
AF:
0.0210
AC:
938
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00723
AC:
189
AN:
26134
East Asian (EAS)
AF:
0.000730
AC:
29
AN:
39700
South Asian (SAS)
AF:
0.00276
AC:
238
AN:
86252
European-Finnish (FIN)
AF:
0.00350
AC:
183
AN:
52328
Middle Eastern (MID)
AF:
0.00954
AC:
55
AN:
5766
European-Non Finnish (NFE)
AF:
0.0282
AC:
31300
AN:
1111758
Other (OTH)
AF:
0.0229
AC:
1381
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1746
3492
5239
6985
8731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1264
2528
3792
5056
6320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0247
AC:
3765
AN:
152264
Hom.:
82
Cov.:
31
AF XY:
0.0226
AC XY:
1684
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0373
AC:
1550
AN:
41534
American (AMR)
AF:
0.0310
AC:
474
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5190
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4828
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0233
AC:
1586
AN:
68014
Other (OTH)
AF:
0.0346
AC:
73
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0219
Hom.:
159
Bravo
AF:
0.0280
TwinsUK
AF:
0.0267
AC:
99
ALSPAC
AF:
0.0392
AC:
151
ESP6500AA
AF:
0.0367
AC:
111
ESP6500EA
AF:
0.0238
AC:
129
ExAC
AF:
0.0155
AC:
1831
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0235
EpiControl
AF:
0.0248

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PSMB9-related disorder Benign:1
Jul 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.038
T;T;T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.95
D
MetaRNN
Benign
0.0068
T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
2.0
.;.;M
PhyloP100
5.1
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.90
N;N;N
REVEL
Benign
0.17
Sift
Uncertain
0.0050
D;D;D
Sift4G
Uncertain
0.033
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.15
MPC
0.39
ClinPred
0.047
T
GERP RS
5.4
Varity_R
0.28
gMVP
0.53
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs241419; hg19: chr6-32823948; COSMIC: COSV100841232; COSMIC: COSV100841232; API